Barclays Is Boosting Teva's PT By: Benzinga via Benzinga April 09, 2015 at 16:01 PM EDT Barclays raised its price target on Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) Thursday to $80 and maintained an ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR